The addition of interferon gamma to oral bexarotene therapy with photopheresis for Sézary syndrome

Arch Dermatol. 2005 Sep;141(9):1176-8. doi: 10.1001/archderm.141.9.1176.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Bexarotene
  • Combined Modality Therapy
  • Drug Therapy, Combination
  • Female
  • Humans
  • Injections, Subcutaneous
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Middle Aged
  • Photopheresis*
  • Recombinant Proteins
  • Sezary Syndrome / drug therapy*
  • Skin Neoplasms / drug therapy*
  • Tetrahydronaphthalenes / administration & dosage*

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Tetrahydronaphthalenes
  • Bexarotene